Gasping for breath: Indians battle respiratory issues in world's most polluted city
Two-year-old Sumaiya Ansari, a resident of India's Byrnihat town, which is ranked the world's most polluted metropolitan area by Swiss Group IQAir, was battling breathing problems for several days before she was hospitalised in March and given oxygen support.She is amongst many residents of the industrial town on the border of the northeastern Assam and Meghalaya states - otherwise known for their lush, natural beauty - inflicted by illnesses that doctors say are likely linked to high exposure to pollution.advertisementByrnihat's annual average PM2.5 concentration in 2024 was 128.2 micrograms per cubic meter, according to IQAir, over 25 times the level recommended by the WHO.
PM2.5 refers to particulate matter measuring 2.5 microns or less in diameter that can be carried into the lungs, causing deadly diseases and cardiac problems."It was very scary, she was breathing like a fish," said Abdul Halim, Ansari's father, who brought her home from the hospital after two days. According to government data, the number of respiratory infection cases in the region rose to 3,681 in 2024 from 2,082 in 2022.
Ibamilari Dkhar, 5, sits on her mother's lap as they wait for consultation inside a primary healthcare centre as acute respiratory infections surge in the town of Byrnihat. (Photo: Reuters)
advertisement"Ninety percent of the patients we see daily come either with a cough or other respiratory issues," said Dr. J Marak of Byrnihat Primary Healthcare Centre.Residents say the toxic air also causes skin rashes and eye irritation, damages crops, and restricts routine tasks like drying laundry outdoors."Everything is covered with dust or soot," said farmer Dildar Hussain.Critics say Byrnihat's situation reflects a broader trend of pollution plaguing not just India's cities, including the capital Delhi, but also its smaller towns as breakneck industrialisation erodes environmental safeguards.Unlike other parts of the country that face pollution every winter, however, Byrnihat's air quality remains poor throughout the year, government data indicates.Home to about 80 industries - many of them highly polluting - experts say the problem is exacerbated in the town by other factors like emissions from heavy vehicles, and its "bowl-shaped topography"."Sandwiched between the hilly terrain of Meghalaya and the plains of Assam, there is no room for pollutants to disperse," said Arup Kumar Misra, chairman of Assam's pollution control board.The town's location has also made the solution tougher, with the states shifting blame to each other, said a Meghalaya government official who did not want to be named.Since the release of IQAir's report in March, however, Assam and Meghalaya have agreed to form a joint committee and work together to combat Byrnihat's pollution.Must Watch
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Gaza's Al-Amal hospital 'virtually out of service': WHO
Geneva: The Al-Amal Hospital in Gaza, one of the few still operating in the Palestinian territory, is now "virtually out of service" due to intense military activity, the head of the WHO said Monday. "Access to the hospital is obstructed, preventing new patients from reaching care, and leading to more preventable deaths," the World Health Organization's director-general Tedros Adhanom Ghebreyesus posted on X. Tedros said two emergency medical teams - one local, the other international - "are still doing their best to serve the remaining patients with the limited medical supplies left on the premises." "With the closure of Al-Amal, Nasser Medical Complex is now the only remaining hospital with an intensive care unit in Khan Younis," he said. The WHO said June 5 that al-Nasser and Al-Amal hospitals were unable to fully treat the wounded that continue to pour in because of serious shortages of medicines and medical supplies after two months of total blockade. Israeli authorities have recently allowed in some humanitarian aid, but way less than what is needed. Nearly 20 months of relentless war, triggered by Hamas' October 7, 2023 attacks on Israel, has created one of the most serious humanitarian crises in the world, with civilians exhausted by bombardments, forced displacement and hunger.
Indian Express
7 hours ago
- Indian Express
Should Type 5 diabetes be a category at all? Top diabetologists question lack of evidence, data
Top endocrinologists have questioned the way Malnutrition-Related Diabetes Mellitus (MRDM) has been hastily rechristened as Type 5 diabetes by the International Diabetes Federation (IDF). In an expert review, Dr Anoop Misra (chairman, Fortis C-DOC Hospital for Diabetes and Allied Sciences), Dr Ambrish Mithal (chairman, Endocrinology and Diabetes at Max Healthcare) and Dr Shashank Joshi (diabetologist, Lilavati Hospital, Mumbai) have argued that the new classification runs ahead without robust modern evidence or clearly defined diagnostic criteria. Their critical analysis was published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews recently. 'Reclassifying MRDM as Type 5 diabetes is premature and not supported by current evidence,' they wrote. They argue that MRDM, though first recognised in 1985, was declassified in 1999 due to poor evidence. They say the same holds true today as overlapping symptoms continue to be misleading, the body mass index (BMI) criteria are considered outdated and there is not enough data to warrant a separate type of diabetes. 'We still need rigorous research and definitive biomarkers for such a classification. Besides, there has to be a global consensus,' says Dr Misra. Excerpts: Why can't MRDM be classified as Type 5 diabetes? There's no conclusive evidence that MRDM is a distinct disease rather than a variant or complication of existing diabetes types. Only a distinct phenotype (traits which define the 'what' of a disease) with robust data different from established types merits new classification. MRDM overlaps with other types of diabetes — type 1 (due to autoimmune markers in some cases), type 2 (with insulin resistance or secretory defects), and secondary diabetes (when the pancreas doesn't produce enough digestive enzymes). There's inadequate evidence. Only a few, small-scale studies, such as the 2022 study by Lontchi-Yimagou, exist. Rest are 25-40 year old data, some of which is mostly clinical. These studies are largely cross-sectional and limited in scope, sample size and generalizability. The American Diabetes Association (ADA) and WHO have never formally acknowledged type 3 or type 4 diabetes, making the proposal of a 'type 5' both arbitrary, confusing and unacceptable. What's needed for a classification? A valid classification demands a clearly distinct cause or causes, well-defined diagnostic criteria, international consensus and therapeutic utility. MRDM does not currently satisfy these requirements. Did MRDM ever receive the attention it deserved? The WHO classified it as a separate category in 1985 and it was discussed in international diabetes forums such as the 1976 IDF Congress. However, this attention waned due to the poor quality and limited quantity of research, which was largely descriptive and observational. Eventually, the WHO removed MRDM from its classification in 1999, citing insufficient evidence. In India, MRDM has become increasingly rare. Many experts report not encountering it at all, suggesting its relevance has significantly declined. Should MRDM be treated as a type or a subset of diabetes? MRDM is best viewed not as a separate type of diabetes but as a subset or modified form of existing types, most likely falling under secondary diabetes or as a variant of type 1 or type 2 diabetes. This type is influenced by factors such as chronic undernutrition. Defining it as a distinct 'type' risks oversimplification and could introduce unnecessary confusion in diagnosis and management. What is the classification's impact in India? India historically played a major role in defining and reporting MRDM, contributing to a significant volume of early literature. But MRDM was also reported from many other tropical countries. However, current data reveal a steep decline in the prevalence of undernutrition (proxy by BMI). For instance, thinness among women aged 20–54 dropped from 31.7% in 1999 to 14.2% in 2021. Moreover, many individuals with low BMI in India are constitutionally thin and not necessarily malnourished or unhealthy. Reintroducing MRDM as a major category today risks diverting clinical attention and public health resources away from the pressing and widespread problem of type 2 diabetes, which remains the dominant and surging diabetes burden in India. What more evidence is needed? We need large-scale, prospective cohort studies with long-term follow-up; detailed nutritional, immunological and metabolic profiling; insulin secretion and sensitivity assessments using gold-standard methods; standardized malnutrition definitions; and comprehensive genetic research. Without this evidence base, the proposal to reclassify MRDM is premature, unsubstantiated and unacceptable. How does Type 5 classification hamper treatment protocol? Classifying MRDM as 'Type 5 diabetes' may introduce more confusion than clarity. It suggests a degree of diagnostic and therapeutic precision that does not exist. Moreover, such a label does not provide actionable clinical guidance, as patients show variable insulin needs and mixed autoimmune markers. It could also mislead policymakers and healthcare providers, diverting attention and funding from more prevalent and well-characterized diabetes forms such as type 2.
News18
9 hours ago
- News18
Are You At Risk? Key Breast Cancer Triggers To Know
Last Updated: Breast cancer is one of the most common types of cancer that affect women across the globe. Early detection and screening improves the chances of successful treatment and recovery. Breast cancer is one of the most common types of cancer worldwide, affecting women. It develops when cells in the breast begin to grow uncontrollably, leading to the formation of tumours. Most breast cancers originate in the milk ducts and may spread to surrounding breast tissue and, eventually, to other parts of the body. When cancer spreads to organs far from its original site, the condition is known as metastasis and is classified as Stage 4 cancer – the most advanced stage, with the lowest survival rate. This makes early detection and screening vital for improving the chances of successful treatment and recovery. With that in mind, let's explore some of the key risk factors that may increase the likelihood of developing breast cancer. Genetic Factors Certain inherited genetic mutations – most notably in the BRCA1 and BRCA2 genes – can significantly increase the risk of developing breast cancer. As these mutations are passed down through families, individuals with a strong family history of breast cancer are considered more vulnerable to the disease. Genetic testing and counselling can help assess this risk and guide preventive measures. Lifestyle Factors Certain lifestyle factors, either in isolation or in combination, play a major role in increasing the risk of breast cancer. This is particularly true for women who are in their 40s. Obesity, especially for women in the postmenopausal phase, is one of the major lifestyle-related risk factors for breast cancer. Habitual smoking, too, may act towards escalating the chances of developing the disease. Alcohol consumption is another lifestyle-related choice that has been identified as a risk factor for breast cancer. Research suggests that there is a link between a woman's reproductive history and her risk of developing breast cancer. Women who give birth earlier in life and breastfeed their child tend to have lower chances of developing breast cancer. WHO and IARC have stated that breastfeeding has a protective effect against breast cancer. Hormones Early menarche and late menopause are two known risk factors for breast cancer. Women who experience either one or both have higher-than-usual exposure to estrogen. This prolonged exposure may put them at a higher risk of developing breast cancer. Sustained hormone replacement therapy (HRT) also increases may serve as a significant risk factor. First Published:
